<?xml version='1.0' encoding='utf-8'?>
<document id="30326170"><sentence text="Interaction between warfarin and cannabis." /><sentence text="Delta-9-tetrahydrocannabinol (THC), the main psychoactive cannabinoid in cannabis, may inhibit the cytochrome P450 enzyme CYP2C9"><entity charOffset="0-28" id="DDI-PubMed.30326170.s2.e0" text="Delta-9-tetrahydrocannabinol" /><entity charOffset="30-33" id="DDI-PubMed.30326170.s2.e1" text="THC" /><entity charOffset="58-69" id="DDI-PubMed.30326170.s2.e2" text="cannabinoid" /><pair ddi="false" e1="DDI-PubMed.30326170.s2.e0" e2="DDI-PubMed.30326170.s2.e0" /><pair ddi="false" e1="DDI-PubMed.30326170.s2.e0" e2="DDI-PubMed.30326170.s2.e1" /><pair ddi="false" e1="DDI-PubMed.30326170.s2.e0" e2="DDI-PubMed.30326170.s2.e2" /><pair ddi="false" e1="DDI-PubMed.30326170.s2.e1" e2="DDI-PubMed.30326170.s2.e1" /><pair ddi="false" e1="DDI-PubMed.30326170.s2.e1" e2="DDI-PubMed.30326170.s2.e2" /></sentence><sentence text=" Consequently, cannabis use might infer a risk of drug-drug interaction with substrates for this enzyme, which includes drugs known to have a narrow therapeutic window" /><sentence text=" In this study, we describe a case report of a 27-year-old man treated with warfarin due to mechanical heart valve replacement who presented with elevated international normalized ratio (INR) value (INR = 4" /><sentence text="6) following recreational cannabis use" /><sentence text=" We conducted a review of the available literature, using the PubMed and EMBASE databases while following PRISMA guidelines" /><sentence text=" Following screening of 85 articles, three eligible articles were identified, including one in vitro study and two case reports" /><sentence text=" The in vitro study indicated that THC inhibits the CYP2C9-mediated metabolism of warfarin"><entity charOffset="35-38" id="DDI-PubMed.30326170.s8.e0" text="THC" /><entity charOffset="82-90" id="DDI-PubMed.30326170.s8.e1" text="warfarin" /><pair ddi="false" e1="DDI-PubMed.30326170.s8.e0" e2="DDI-PubMed.30326170.s8.e0" /><pair ddi="false" e1="DDI-PubMed.30326170.s8.e0" e2="DDI-PubMed.30326170.s8.e1" /></sentence><sentence text=" One case study reported of a man who on two occasions of increased marijuana use experienced INR values above 10 as well as bleeding" /><sentence text=" The other case study reported of a patient who initiated treatment with a liquid formulation of cannabidiol for the management of epilepsy, ultimately necessitating a 30% reduction in warfarin dose to maintain therapeutic INR values"><entity charOffset="97-108" id="DDI-PubMed.30326170.s10.e0" text="cannabidiol" /></sentence><sentence text=" The available, although sparse, data suggest that use of cannabinoids increases INR values in patients receiving warfarin"><entity charOffset="58-70" id="DDI-PubMed.30326170.s11.e0" text="cannabinoids" /></sentence><sentence text=" Until further data are available, we suggest patients receiving warfarin be warned against cannabis use" /><sentence text="" /></document>